Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label Trial
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label Trial
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 9, Issue 5, Pages 1246
Publisher
MDPI AG
Online
2020-04-29
DOI
10.3390/jcm9051246
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis
- (2019) Taesik Gwag et al. JOURNAL OF HEPATOLOGY
- A New Targeted Lipidomics Approach Reveals Lipid Droplets in Liver, Muscle and Heart as a Repository for Diacylglycerol and Ceramide Species in Non-Alcoholic Fatty Liver
- (2019) Christina Preuss et al. Cells
- An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases
- (2019) Shi-Hui Law et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients
- (2019) Mika Hilvo et al. EUROPEAN HEART JOURNAL
- Altered Lipidome Composition Is Related to Markers of Monocyte and Immune Activation in Antiretroviral Therapy Treated Human Immunodeficiency Virus (HIV) Infection and in Uninfected Persons
- (2019) Emily R. Bowman et al. Frontiers in Immunology
- Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials
- (2019) Paul E Sax et al. CLINICAL INFECTIOUS DISEASES
- Use of a metabolomic approach to non-invasively diagnose non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus
- (2018) Fernando Bril et al. DIABETES OBESITY & METABOLISM
- Relationship between serum bilirubin levels and cardiovascular disease
- (2018) Sunghwan Suh et al. PLoS One
- Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA)
- (2018) Lucia Taramasso et al. BMC INFECTIOUS DISEASES
- Switching to coformulated rilpivirine (RPV), emtricitabine (FTC) and tenofovir alafenamide from either RPV, FTC and tenofovir disoproxil fumarate (TDF) or efavirenz, FTC and TDF: 96-week results from two randomized clinical trials
- (2018) D Hagins et al. HIV MEDICINE
- Changes in plasma lipidome following initiation of antiretroviral therapy
- (2018) Janine M. Trevillyan et al. PLoS One
- Coronary Artery Disease Manifestations in HIV: What, How, and Why
- (2018) Arjun Sinha et al. CANADIAN JOURNAL OF CARDIOLOGY
- Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma and primary sclerosing cholangitis
- (2018) Jesus M Banales et al. HEPATOLOGY
- Novel Lipidomic Biomarkers in Hyperlipidemia and Cardiovascular Diseases: An Integrative Biology Analysis
- (2017) Sneha Rai et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Cardiovascular disease in patients with HIV
- (2017) Flavia Ballocca et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Improvement of lipid profiles when switching from efavirenz to rilpivirine in HIV-infected patients with dyslipidemia
- (2016) Pornpimol Thamrongwonglert et al. HIV CLINICAL TRIALS
- Molecular mechanisms of serotonergic action of the HIV-1 antiretroviral efavirenz
- (2016) Dhwanil A. Dalwadi et al. PHARMACOLOGICAL RESEARCH
- Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
- (2016) Amedeo Lonardo et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Enhancing metabolomics research through data mining
- (2015) Ibon Martínez-Arranz et al. Journal of Proteomics
- Fatty acyl composition of lysophosphatidylcholine is important in atherosclerosis
- (2015) O.A. Akerele et al. MEDICAL HYPOTHESES
- Stress, the Stress System and the Role of Glucocorticoids
- (2015) Nicolas C. Nicolaides et al. NEUROIMMUNOMODULATION
- Ceramide as a Mediator of Non-Alcoholic Fatty Liver Disease and Associated Atherosclerosis
- (2015) Takhar Kasumov et al. PLoS One
- Rilpivirine Versus Efavirenz with Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naïve HIV-1–Infected Patients with HIV-1 RNA ≤100,000 Copies/mL: Week 96 Pooled ECHO/THRIVE Subanalysis
- (2014) Georg Behrens et al. AIDS PATIENT CARE AND STDS
- Lipid Levels and Changes in Body Fat Distribution in Treatment-Naive, HIV-1–Infected Adults Treated With Rilpivirine or Efavirenz for 96 Weeks in the ECHO and THRIVE Trials
- (2014) Pablo Tebas et al. CLINICAL INFECTIOUS DISEASES
- HIV infection and cardiovascular disease
- (2014) L. G. Hemkens et al. EUROPEAN HEART JOURNAL
- Lack of mitochondrial toxicity of darunavir, raltegravir and rilpivirine in neurons and hepatocytes: a comparison with efavirenz
- (2014) A. Blas-Garcia et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Plasma Lipidomic Profiling of Treated HIV-Positive Individuals and the Implications for Cardiovascular Risk Prediction
- (2014) Gerard Wong et al. PLoS One
- Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors
- (2013) Edana Cassol et al. BMC INFECTIOUS DISEASES
- Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids
- (2013) Matej Orešič et al. DIABETOLOGIA
- Plasma Lipid Composition and Risk of Developing Cardiovascular Disease
- (2013) Celine Fernandez et al. PLoS One
- Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population
- (2012) Alison J. Rodger et al. AIDS
- Obesity-Dependent Metabolic Signatures Associated with Nonalcoholic Fatty Liver Disease Progression
- (2012) J. Barr et al. JOURNAL OF PROTEOME RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search